This dose is also close to RSV regimens previously reported in VPA-induced animal models of ASD, in which RSV was administered at approximately 3.6 mg/kg for 1213 days (Fontes-Dutra et al., 2018
Vidal-Casariego A, Burgos-Pelez R, Martnez-Faedo C, Calvo-Gracia F, Valero-Zanuy M, Luengo-Prez LM, Cuerda-Comps C
On the other hand, the risks of HHF (HR 0.93, 95% CI 0.831.04 with GLP-1RAs and HR 0.69, 95% CI 0.610.79 with SGLT2is) and composite kidney outcomes excluding macroalbuminuria (HR 0.92, 95% CI 0.801.06 with GLP-1RAs and HR 0.55, 95% CI 0.480.64 with SGLT2is) significantly reduced with SGLT2is only
a mass in the neck, dysphagia, dyspnea, persistent hoarseness)
NCT04184622 ), and in SURPASS-2 it outperformed semaglutide on glucose and weight endpoints in type 2 diabetes ( Fras et al., NEJM 2021 )
Reconstitute lyophilized CJC-1295 using bacteriostatic water